QIAGEN N.V. (0RLT)

Overview

Founded in 1984 and headquartered in Venlo, the Netherlands, QIAGEN N.V. is a global leader in providing comprehensive solutions that convert biological materials into valuable molecular insights. The company’s innovative portfolio spans a wide range of sectors including molecular diagnostics, academia, pharmaceutical, and applied testing. QIAGEN is dedicated to facilitating the process of acquiring insights from biological samples through its extensive array of technologies and products, designed to support various stages of molecular analysis.

Products and Services

• Sample Technology Consumables: QIAGEN offers an array of consumables for sample preparation, including nucleic acid stabilization and purification kits tailored for an array of primary sample materials. They provide solutions for manual and automated processing that support genotyping, gene expression analysis, and the assessment of viral and bacterial loads. Technologies include silica membranes and magnetic bead-based approaches.
• Nucleic Acid Purification Instruments: The company manufactures instruments that enable the purification of nucleic acids along with necessary accessories, helping streamline the preparation process in laboratories.
• PCR Consumables and Instruments: QIAGEN offers a comprehensive portfolio of PCR consumables, including quantitative PCR (qPCR) and reverse transcription kits designed for various analyses such as gene expression, genotyping, and gene regulation. This category also encompasses a range of PCR instruments, including innovative solutions for digital PCR and qPCR, designed for precision and efficiency.
• Human ID and Forensics: The company provides assay consumables for human identification (ID) and forensic purposes, including Short Tandem Repeat (STR) assays and tests for detecting food contamination.
• Assays for Various Diseases and Conditions: QIAGEN develops interferon-gamma release assays for Tuberculosis (TB) testing, along with assays for post-transplant monitoring, viral load determination, prenatal testing, detection of sexually transmitted diseases (STDs), and the Human Papillomavirus (HPV). These offerings are crucial for early detection and monitoring of various conditions and diseases.
• Genomic Variant Analysis: The company provides assays designed for the detailed analysis of genomic variants, such as mutations, insertions, deletions, and fusions. This is crucial for understanding genetic diseases and tailoring personalized medicine approaches.
• Next-Generation Sequencing (NGS): QIAGEN’s NGS solutions include predefined and custom gene panels, library preparation kits, and whole genome amplification products. These enable researchers and clinicians to conduct comprehensive genomic studies and leverage sequencing for diagnostics and research purposes.
• Bioinformatics and Custom Services: In addition to physical products, QIAGEN provides bioinformatics solutions for data analysis and interpretation, as well as custom laboratory and genomic services tailored to meet specific research needs, enabling customers to achieve their unique objectives in molecular analysis.